What do systematic reviews say?

766 questions · 806 findings · 76 reviews · ENT

Sort:Best matchNewestHighest certainty Download CSV

No studies found 293 · 36.4%GRADE not reported 6 · 0.7%Very low 244 · 30.3%Low 170 · 21.1%Moderate 85 · 10.5%High 8 · 1%

Roxithromycin vs placebo

Mean change from baseline of SNOT‐20 at 3 months post‐treatment Scale from: 0 to 5 · chronic rhinosinusitis in adults

1 finding from 1 review

Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 64 participants
Low

Corticosteroids vs placebo

Number of children with clinical adverse event: vertigo · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

Corticosteroids showed no clear difference in vertigo compared with placebo (low certainty).

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 0.39 [0.04, 3.57]
2 studies · 60 participants
Low

Corticosteroids vs placebo

Dizziness Handicap Inventory score · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low

Corticosteroids vs placebo

Caloric extent of recovery (improvement as a % in lateralisation of electronystagmography on caloric testing) · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 89 participants
Low

Corticosteroids vs placebo

Complete caloric recovery · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

Corticosteroids may leads to higher complete caloric recovery compared with placebo (low certainty).

2 findings from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 2.81 [1.32, 6]
2 studies · 50 participants
Low
Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
RR 1.58 [0.45, 5.62]
2 studies · 89 participants
Low

Corticosteroids vs placebo

Adverse effects · Patients with idiopathic acute vestibular dysfunction (vestibular neuritis)

1 finding from 1 review

Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) 2011 · Cochrane Headline outcomes only
no estimate extracted
1 study · 73 participants
Moderate